Policy Blog

This week: Prasad does the Hokey Pokey at CBER as MAHA continues to take root across federal programs.

This Week: From Medicare’s potential $2.5 billion in savings through service cuts and the FDA’s leadership exodus to NIH funding slashed to just 4% of applications and Trump’s drug pricing ultimatum, seismic policy shifts and financial upheavals are reshaping every corner of America’s healthcare landscape.

This Week: It’s HOT!

This Week: Kennedy weighs in on prevention and vaccines, more BBB and Prior Auth news, and FDA opens the vault on its drug decisions.

This Week: The Big Beautiful Bill, More Vaccine Drama… and a July 4th Recess

This week: The FDA has launched a new voucher program to fast-track drug approvals for companies addressing national health priorities, aiming to lower costs, boost domestic manufacturing, and accelerate innovation.

This Week: RFK Cleans House – Dismantles CDC vaccine advisory committee and rebuilds it in his image.